[Expression of recombinant human hemoglobin in plants]

Area of Science:

• Biotechnology
• Molecular Biology
• Plant Science

Context:

• Recombinant protein production for therapeutic use requires safe and economical hosts.
• Transgenic organisms are being explored to meet these demands.
• Plant-based systems offer unique advantages in biopharmaceutical manufacturing.

Purpose:

• To evaluate the potential of transgenic plants as a cost-effective system for producing therapeutic proteins.
• To highlight the advantages of plant-based systems over other transgenic platforms.
• To assess the feasibility of using plants for low-cost, low-risk protein production.

Summary:

• Transgenic plants can produce therapeutic proteins, such as hemoglobin, with reduced costs and minimal pathogen contamination risks.
• Plant systems are identified as a highly economical transgenic approach due to inexpensive biomass acquisition.
• Field-based biomass production in plants offers a scalable and affordable manufacturing solution.

Impact:

• This research supports the development of more affordable biopharmaceuticals.
• It promotes the use of plants in the biopharmaceutical industry.
• It offers a sustainable and safe alternative for therapeutic protein production.